AMPCO

AMPCO Pharma is a South Korean biotechnology company specializing in the development of next-generation antimicrobial peptides (AMPs) to combat multidrug-resistant (MDR) bacteria. The company utilizes a proprietary design platform to engineer synthetic peptides that mimic the natural innate immune system's ability to disrupt bacterial membranes while maintaining low toxicity to human cells. Their research focus extends beyond systemic antibiotics to include topical treatments for skin infections and inflammatory conditions like atopic dermatitis. By addressing the global threat of 'superbugs,' AMPCO Pharma aims to provide novel therapeutic options where traditional small-molecule antibiotics have failed.